相关实验视频
Updated: Sep 13, 2025

08:31
Porous Silicon Microparticles for Delivery of siRNA Therapeutics
Published on: January 15, 2015
11.0K
对生物寡合体与siRNA复合的分子洞察力,用于治疗应用
Desh Deepak Yadav1, Debdip Bhandary2, Pradip Paik1
1School of Biomedical Engineering, Indian Institute of Technology (BHU) Varanasi, Varanasi, Uttar Pradesh 221005, India.
The journal of physical chemistry. B
|July 31, 2025
概括
作为小干扰RNA (siRNA) 传递的载体,N-烯-氨甲基 (NAPA) 寡合体显示出有前途的潜力. 分子动力学模拟揭示了稳定的复合物,其中五聚为向RNA疗法提供了最大的紧缩和稳定性.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 分子生物学分子生物学
背景情况:
- 小干扰RNA (siRNA) 对癌症等疾病具有治疗潜力,但面临着传递挑战.
- 有效的载体对于克服siRNA的局限性至关重要,包括结构和功能问题.
- 生物相容和生物降解材料对于开发高效的siRNA输送系统至关重要.
研究的目的:
- 用分子动力学 (MD) 模拟来研究siRNA与N-烯-氨氨酸甲基 (NAPA) 寡合物的复合.
- 了解不同长度的siRNA和NAPA寡合体 (从单体到体) 之间的分子级结合机制.
- 评估siRNA-NAPA复合体的结构和动态参数,以潜在的治疗应用.
主要方法:
- 用原子分子动力学 (MD) 模拟来建模siRNA与NAPA寡合体的复杂化.
- 分析包括关键参数,如槽宽度,接触号,结,辐射分布函数,溶剂可访问性和根-平均-平方波动.
- 结合动力学使用兰格穆尔第一阶吸附模型进行了评估.
主要成果:
- 稳定的siRNA-NAPA复合体在20纳秒内形成,主要是通过siRNA槽中的键.
- 结合遵循兰格穆尔吸附动力学,随着从单体到体的长度增加,结合的寡合体数量减少.
- siRNA-pentamer复合体表现出最高的紧缩 (约18%) 并显示出优越的稳定性.
结论:
- N-烯-氨甲基 (NAPA) 寡合体显示出作为小干扰RNA (siRNA) 的有效载体的显著潜力.
- 该研究提供了关于siRNA-NAPA复合体形成的分子层面见解,这对于设计有针对性的传递系统至关重要.
- 这些发现通过突出有希望的载体材料,有助于推进基于RNA的疗法.
相关概念视频
siRNA - Small Interfering RNAs
17.0K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.0K
RNA Interference
26.5K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.5K
Experimental RNAi
6.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.3K
Ligand Binding Sites
13.2K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
13.2K
MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K

